{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:43:17Z","timestamp":1783406597860,"version":"3.54.6"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,1,19]]},"DOI":"10.1001\/jama.2020.25864","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T12:50:58Z","timestamp":1611060658000},"page":"254","source":"Crossref","is-referenced-by-count":339,"title":["Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19"],"prefix":"10.1001","volume":"325","author":[{"given":"Renato D.","family":"Lopes","sequence":"first","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"},{"name":"Brazilian Clinical Research Institute, S\u00e3o Paulo, Brazil"},{"name":"Rede D\u2019Or S\u00e3o Luiz, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane V. S.","family":"Macedo","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Hospital S\u00e3o Luiz Jabaquara, S\u00e3o Paulo, Brazil"},{"name":"Santa Casa de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro G. M.","family":"de Barros E Silva","sequence":"additional","affiliation":[{"name":"Brazilian Clinical Research Institute, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata J.","family":"Moll-Bernardes","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago M.","family":"dos Santos","sequence":"additional","affiliation":[{"name":"Brazilian Clinical Research Institute, S\u00e3o Paulo, Brazil"},{"name":"Insper Institute of Education and Research, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Mazza","sequence":"additional","affiliation":[{"name":"Brazilian Clinical Research Institute, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Feldman","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Hospital S\u00e3o Luiz An\u00e1lia Franco, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"D\u2019Andr\u00e9a Saba Arruda","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Hospital S\u00e3o Luiz S\u00e3o Caetano, S\u00e3o Caetano do Sul, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Den\u00edlson C.","family":"de Albuquerque","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina S.","family":"Camiletti","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Rede D\u2019Or S\u00e3o Luiz, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a S.","family":"de Sousa","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil"},{"name":"Federal University of Rio de Janeiro, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago C.","family":"de Paula","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Luiz Jabaquara, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla G. D.","family":"Giusti","sequence":"additional","affiliation":[{"name":"Hospital Villa Lobos, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael A. M.","family":"Domiciano","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Luiz An\u00e1lia Franco, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia M.","family":"Noya-Rabelo","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Rafael, Salvador, Brazil"},{"name":"Escola Bahiana de Medicina e Sa\u00fade P\u00fablica, Salvador, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Rafael, Salvador, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor A.","family":"Loures","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Luiz An\u00e1lia Franco, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo M.","family":"Dion\u00edsio","sequence":"additional","affiliation":[{"name":"Hospital SinoBrasileiro, Osasco, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thyago A. B.","family":"Furquim","sequence":"additional","affiliation":[{"name":"Hospital SinoBrasileiro, Osasco, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio A.","family":"De Luca","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Luiz Morumbi, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdtalo B.","family":"dos Santos Sousa","sequence":"additional","affiliation":[{"name":"Hospital S\u00e3o Luiz Morumbi, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno S.","family":"Bandeira","sequence":"additional","affiliation":[{"name":"Hospital Caxias D\u2019Or, Duque de Caxias, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleverson N.","family":"Zukowski","sequence":"additional","affiliation":[{"name":"Hospital Copa D\u2019Or, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo G. G.","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Hospital Quinta D\u2019Or, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noara B.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Hospital Santa Luzia, Bras\u00edlia, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffer L.","family":"de Moraes","sequence":"additional","affiliation":[{"name":"Hospital Assun\u00e7\u00e3o, S\u00e3o Bernardo do Campo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o L. F.","family":"Petriz","sequence":"additional","affiliation":[{"name":"Hospital Barra D\u2019Or, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana M.","family":"Pimentel","sequence":"additional","affiliation":[{"name":"Hospital Niter\u00f3i D\u2019Or, Niter\u00f3i, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline S.","family":"Miranda","sequence":"additional","affiliation":[{"name":"Hospital Copa Star, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara E.","family":"de Jesus Abufaiad","sequence":"additional","affiliation":[{"name":"Hospital Oeste D\u2019Or, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Gibson","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Granger","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Alexander","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga F.","family":"de Souza","sequence":"additional","affiliation":[{"name":"D\u2019Or Institute for Research and Education, Rio de Janeiro, Brazil"},{"name":"Rede D\u2019Or S\u00e3o Luiz, S\u00e3o Paulo, Brazil"},{"name":"Hospital Copa Star, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"BRACE CORONA Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10","key":"joi200140r1","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2.","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"issue":"5","key":"joi200140r2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11906-008-0076-0","article-title":"Pharmacologic modulation of ACE2 expression.","volume":"10","author":"Soler","year":"2008","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"joi200140r3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s11906-014-0420-5","article-title":"ACE2: angiotensin II\/angiotensin-(1-7) balance in cardiac and renal injury.","volume":"16","author":"Varagic","year":"2014","journal-title":"Curr Hypertens Rep"},{"key":"joi200140r4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102907","article-title":"SARS-CoV-2 and ACE2.","volume":"58","author":"Chung","year":"2020","journal-title":"EBioMedicine"},{"issue":"18","key":"joi200140r5","first-page":"1769","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"issue":"25","key":"joi200140r6","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMe2012924","article-title":"Inhibitors of the renin\u2013angiotensin\u2013aldosterone system and Covid-19.","volume":"382","author":"Jarcho","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"joi200140r7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jacc.2020.05.069","article-title":"Randomized trials versus common sense and clinical observation.","volume":"76","author":"Fanaroff","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"joi200140r8","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/cid\/cix1032","article-title":"Rigorous clinical trial design in public health emergencies is essential.","volume":"66","author":"Ellenberg","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"joi200140r9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jacc.2019.11.043","article-title":"New approaches to conducting randomized controlled trials.","volume":"75","author":"Fanaroff","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"joi200140r10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ahj.2020.05.002","article-title":"Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.","volume":"226","author":"Lopes","year":"2020","journal-title":"Am Heart J"},{"issue":"12","key":"joi200140r11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.118.004755","article-title":"Days alive and out of hospital.","volume":"11","author":"Fanaroff","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"21","key":"joi200140r12","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19.","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"issue":"19","key":"joi200140r13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"joi200140r14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/rssc.2005.54.issue-3","article-title":"Generalized additive models for location, scale and shape.","volume":"54","author":"Rigby","year":"2005","journal-title":"J R Stat Soc Ser C Appl Stat"},{"issue":"17","key":"joi200140r16","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with Covid-19.","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"issue":"7047","key":"joi200140r17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure.","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"25","key":"joi200140r18","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of Covid-19.","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"issue":"25","key":"joi200140r19","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of Covid-19.","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"joi200140r20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension.","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"joi200140r21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"issue":"7","key":"joi200140r22","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China.","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"6","key":"joi200140r23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235248","article-title":"Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, in a sample of infected Italian citizens.","volume":"15","author":"Bravi","year":"2020","journal-title":"PLoS One"},{"issue":"7","key":"joi200140r24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.21037\/atm","article-title":"The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.","volume":"8","author":"Huang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"10238","key":"joi200140r26","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","article-title":"Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital.","volume":"395","author":"de Abajo","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"joi200140r27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19).","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"joi200140r28","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1161\/HYPERTENSIONAHA.120.15289","article-title":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients.","volume":"76","author":"Pan","year":"2020","journal-title":"Hypertension"},{"issue":"7","key":"joi200140r29","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19).","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"joi200140r30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/HYPERTENSIONAHA.120.15712","article-title":"What kind of evidence is needed to dictate practice regarding inhibitors of the renin-angiotensin system in COVID-19?","volume":"76","author":"Elijovich","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"joi200140r31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ejhf.v22.6","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are not associated with severe COVID-19 infection in a multi-site UK acute hospital trust.","volume":"22","author":"Bean","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"joi200140r33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA statement addresses concerns.","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J Card Fail"},{"issue":"3","key":"joi200140r34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jacc.2008.03.048","article-title":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure.","volume":"52","author":"Fonarow","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"joi200140r35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11906-020-01057-x","article-title":"Is hypertension a real risk factor for poor prognosis in the COVID-19 pandemic?","volume":"22","author":"Drager","year":"2020","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"joi200140r36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity is a risk factor for severe COVID-19 infection.","volume":"142","author":"Sattar","year":"2020","journal-title":"Circulation"},{"issue":"19","key":"joi200140r37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19.","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"issue":"10256","key":"joi200140r38","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0140-6736(20)31862-6","article-title":"Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II).","volume":"396","author":"Furtado","year":"2020","journal-title":"Lancet"},{"issue":"10238","key":"joi200140r39","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19.","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"joi200140r40","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3346\/jkms.2015.30.12.1800","article-title":"Persistence with antihypertensive medications in uncomplicated treatment-na\u00efve patients.","volume":"30","author":"Ah","year":"2015","journal-title":"J Korean Med Sci"},{"key":"joi200140r15","volume-title":"R: A Language and Environment for Statistical Computing v. 3.5. 1","year":"2019"},{"key":"joi200140r25","doi-asserted-by":"crossref","unstructured":"Khera? R, Clark? C, Lu? Y, . Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and death in hypertensive patients with coronavirus disease-19.? medRxiv. 2020:2020.05.17.20104943. doi:10.1101\/2020.05.17.20104943.","DOI":"10.1101\/2020.05.17.20104943"},{"key":"joi200140r32","unstructured":"European Society of Cardiology Council on Hypertension. Position statement on ACE-inhibitors and angiotensin receptor blockers. Published March 13, 2020. Accessed October 27, 2020. https:\/\/www.escardio.org\/Councils\/Council-on-Hypertension-(CHT)\/News\/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang?"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2775280\/jama_lopes_2021_oi_200140_1610652626.43702.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T12:51:15Z","timestamp":1611060675000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2775280"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1,19]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.25864","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739392014.793582364","asserted-by":"object"}]},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}